
































































Feasibility of a Dielectric Elastomer Augmented Aorta
Morgan Almanza,* Francesco Clavica, Jonathan Chavanne, David Moser, Dominik Obrist,
Thierry Carrel, Yoan Civet, and Yves Perriard
Although heart transplantation is a gold standard for severe heart failure,
there is a need for alternative effective therapies. A dielectric-elastomer aorta
is used to augment the physiological role of the aorta in the human circulatory
system. To this end, the authors developed a tubular dielectric elastomer
actuator (DEA) able to assist the heart by easing the deformation of the aorta
in the systole and by increasing its recoil force in the diastole. In vitro
experiments using a pulsatile flow-loop, replicating human physiological flow
and pressure conditions, show a reduction of 5.5% (47 mJ per cycle) of the
heart energy with this device. Here, the controlled stiffness of the DEA graft,
which is usually difficult to exploit for actuators, is perfectly matching the
assistance principle. At the same time, the physiological aortic pressure is
exploited to offer a prestretch to the DEA which otherwise would require an
additional bulky pre-stretching system to reach high performances.
1. Introduction
Heart failure (HF) is a devastating disease that affects more than
11 million people in the United States and Europe and more than
23 million worldwide.[1] The first successful attempt to treat HF
with an artificial assist device in humans dates back to 1966.[2] Al-
though heart transplant is the gold standard for selected patients
suffering from severe heart failure, there is a need for alternative
effective therapies due to the shortage of heart donors. Further
developments of cardiac assist devices could eliminate or delay
the need for a transplant.
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Technological solutions to assist the
heart (Text S1, Supporting Information) can
be divided into two families of devices:
ventricular assist devices (VADs) and aor-
tic counterpulsation devices. On the one
hand, current VADs are based on rotary
pumps (axial and centrifugal pumps) char-
acterized by a single rotating element which
creates a constant flow.[3] On the other
hand, the basic principle of aortic coun-
terpulsation allows an increase of coronary
blood flow (during diastole) and unloads
the left ventricle (during systole).[4] In the
intra-aortic balloon pump (IABP, the most
common aortic counterpulsation device), a
balloon is inflated inside the aorta during
the diastolic phase of the heart to increase
aortic pressure (which leads to increased
coronary flow) while presystolic deflation of the balloon de-
creases the afterload pressure. Aortic counterpulsation de-
vice avoids rotary components (associated with high risk of
haemolysis and thrombosis which force patients to use anti-
coagulants during their lifetime[5]) and it ensures pulsatile flow
(which favours capillary perfusion[6]). However, IABP equip-
ment, being pneumatically driven, are bulky and difficult to fully
implant.
Two decades ago, Pelrine[7] introduced a new family of soft ac-
tuators called dielectric elastomer actuator (DEA). Those DEAs
are made of a hyper-elastic membrane sandwiched between com-
pliant electrodes. When subjected to an electric field, the gener-
ated Maxwell stress causes the membrane to compress out-of-
plane and to expand in-plane. Typical features of dielectric elas-
tomer actuators are: large deformation beyond 100%, fast re-
sponse, and low weight.
After two decades of research on DEAs, mainly oriented to-
ward linear actuator or haptic devices, it is still hard to reap
their potential. First, an initial pre-stretching of the membrane[7]
is required to withstand the high electric field necessary for
a large deformation. Second, DEAs intrinsically behave more
like a controlled stiffness spring than a conventional actuator.
Their native driven compliance behavior results in a complex
force-displacement working area, resembling as a “banana shape
(Figure S23, Supporting Information)” instead of a square do-
main commonly used for classic actuators.[8] To apply the pre-
stretching or to morph the area of operation to more conven-
tional ones, external mechanical systems are needed, such as
positive or negative stiffness springs.[9,10] Those passive elements
add mass and complexity to the design, limiting the advantages of
DEA.
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Figure 1. Working principle of a dielectric-elastomer-augmented aorta (DEAA) for cardiac assist device. A) Physiological behavior of the heart highlighting
the diastolic and systolic phases. B) Pressure–volume characteristic of a biological aorta and of an DEAA. The green line shows a physiological cycle
also corresponding to a cycle operated without assistance. The black line shows the assisted cycle with the corresponding steps. The area delimited
by 1-2-3-4 corresponds to the energy provided by the DEAA. C) DEAA working principle: 1) at end of the diastole, the voltage is applied and the DEA
expands; 2) during the systole, the pressure increases leading to an expansion of the DEA; 3) at end of the systole, the voltage is removed and the DEA
contracts; 4) during the diastole, the pressure decreases leading to a contraction of the DEA.
2. Methods
In the present study, we present the first dielectric-elastomer-
augmented aorta (DEAA). This DEAA consists of a tubular DEA
with an electrically driven compliance. It is designed to assist
the pulsatile nature of the heart by means of an innovative aor-
tic counter-pulsation approach. The possibility of an electrically
driven counterpulsation device paves the way for a fully im-
planted device (not possible for current pneumatically driven aor-
tic counterpulsation devices) and for a high-level cardiac assis-
tance.
DEA pumps have already been developed in the past (Text S2,
Supporting Information). However, the actuator and its applica-
tion has to be thought as a whole to reveal its full potential. Since
a tubular DEA replaces the ascending aorta, it exploits directly
the controlled stiffness of DEAs and by doing so it reaps the full
benefit of DEAs. To the best of our knowledge, no attempt of im-
planting these actuators in human or animals as hemodynamic
support / partial replacement of the muscle function has been re-
ported so far. Therefore, we aim at exploiting this technology for
medical applications starting from an assist device for the fail-
ing heart.
A physiological aorta in healthy patients stores elastic energy in
the systole and releases it during the diastole as indicated by the
green curve in Figure 1. It is known as the Windkessel effect.[11]
Despite the pulsatile nature of the cardiac pumping, the compli-
ance of the aorta ensures a rather constant peripheral blood flow
(Windkessel effect). In our assist device, the tubular DEA physi-
ologically replaces a part of the ascending aorta, as shown in Fig-
ure 1C, to unload the left ventricle which provides most of the
heart energy. In the assisted operation, the stiffness/compliance
is electrically controlled to have different values at expansion or
contraction phase (steps 2 and 4 in the cycle, Figure 1). By provid-
ing energy, this tubular dielectric elastomer (actuator) augments
the role of the aorta with its unique driven compliance.
At the beginning of the systolic phase, voltage is applied (steps
1, Figure 1) to soften the DEAA, allowing it to expand as the ven-
tricle ejects blood out of the aortic valve (steps 2, Figure 1). This
expansion also decreases the afterload seen by the ventricle. At
the beginning of diastole, the aortic valve closes, the voltage is
switched-off (steps 3, Figure 1) causing the DEAA to return to its
contracted shape, thereby augmenting forward flow (steps 4, Fig-
ure 1). The DEAA contracts first because of the vanishing of the
voltage and then because of the decrease of the aortic pressure
(diastole). The area of the cycle (delimited by 1-2-3-4, Figure 1) is
the energy provided by the augmented aorta to the fluid (blood).
In this working principle, the DEA benefits, in terms of per-
formance, from an adequate operating condition. First of all,
the pressure variation, induced by the heart in the aorta, allows
the DEA to circumscribe the cycle (through a difference of com-
pliance when the pressure increases or decreases). Second, the
aforementioned pre-stretching for DEA is provided by the aortic
pressure (no additional complex elements, lowering the energy
density, are required).
Adv. Sci. 2021, 2001974 © 2021 The Authors. Advanced Science published by Wiley-VCH GmbH2001974 (2 of 13)
www.advancedsciencenews.com www.advancedscience.com
Figure 2. Manufacturing process from a commercial film to a tubular dielectric elastomer actuator. 1) Deposition of the carbon base electrode on top
of a silicone film to obtain a module. 2) The module is placed up-side down on a PET support with a silicone adhesion layer (LSR4305+0.3%C). 3) A
second module is placed on top of the previous stack. 4) A final electrode is deposited. 5) A deposition of a silicone layer is done on the lower half of the
stack to glue the layers of the tube in (6) when the tube is rolled around a PMMA tube. 7) The tube is cut across the whole thickness on both extremities
to reach the different electrodes. 8) A conductive silicone (LR 3162) is deposited to connect the electrodes embedding a high voltage cable. 9) Outer
insulation with silicone (Sylgard 186) is done. 10) The inner insulation (Sylgard 186) is done using a protective PMMA tube and PET sheet. 11) The tube
is released from its support. 12) Carbon ink is finally deposited by deep coating to ensure electric shielding and the final tube is obtained
Assuming that the energy provided by the heart is around
0.8 J, producing a DEAA able to provide ≈5–10% of the heart en-
ergy (40–80 mJ) is a milestone. Multi-layer tubular silicone DEAs
are required to reach enough energy for assisting the heart and
reduce the working voltage. Most tubular DEAs that are fabri-
cated and studied[12,13] are based on rolled acrylic (VHB from 3M)
films to obtain a tubular structure. For the fabrication of multi-
layer tubular DEAs based on silicone, only two processes exist:
deep coating[14] and rolling film[15].
In the development of a soft cardiac-assist-device, we replace
and augment the role of the ascending aorta with a tubular DEA.
To this end, we developed a process to achieve a reliable and
highly efficient multilayer tubular DEA from commercial silicone
films. Since the tubular DEA is designed to be implanted, we con-
fined the electric field (100 V.𝜇m−1) inside the DEA tube through
an electrical shield which avoids any electrical field in the sur-
rounding tissue. To fully characterize the assistance of the DEAA
in terms of energy provided, we measured the pressure–volume
characteristic using a custom-made test bench. Finally, to study
the complex interaction between the DEAA and the cardiovascu-
lar system, we tested our device in a pulsatile flow-loop replicat-
ing human physiological flow and pressure conditions.
2.1. Fabrication of the Tube
The need of films with constant properties over wide surfaces en-
courages the selection of industrially produced film. A brand new
process is proposed, regarding the aforementioned film, which
are very soft and sold attached to a dedicated support. The fab-
rication process, described in Figure 2, is based on stacking and
rolling commercial films followed by electrical interconnections,
safety encapsulation and shielding.
First a carbon-based electrode is deposited on top of a silicone
film (Elastosil film 2030 200 µm) with its support to make a mod-
ule (① in Figure 2 and in Figure 3B. In panels ② and ③, thanks
to a silicone based adhesion layer,[16] the silicone film and its
electrode are successively transferred up-side down from their
initial support to the stack (the first layer being on a polyethy-
lene terephthalate [PET] substrate). The silicone-based adhesion
layer[16] made of carbon black powder and silicone also smooths
the field concentration and improves the withstand voltage. Af-
ter the deposition of the last electrode, the stack (Figure 3C) is
then cut (④ in Figure 2). The active area is 190 mm long and 35
mm large. The stack is rolled (⑥ in Figure 2) around a tube of 30
mm of diameter, corresponding to the size of human aorta at rest,
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Figure 3. Fabrication results of the DEAA - tubular DEA with eight layers 100 µm thick. A) Photo of the final device. B) Photo of the initial module
(electrode–silicone–PET support). C) Photo of the multilayer structure right before the rolling step. Negatively and positively charged sides are annotated.
D) Highway interconnection realization ongoing. The high voltage wire is embedded in the conductive silicone (LR 3162). E) Cross sectional view of the
different layers under optical microscope. We can distinguish the eight layers of 100 µm thick Elastosil film, the carbon based electrode, the highway
interconnection (LR 3162), and the outer insulation (Sylgard 186).
after a deposition of silicone to glue the layers stacked during the
rolling (⑤ in Figure 2).
In ⑦, the tube is cut at the edges to access electrodes. In ⑧,
the interdigited electrodes are interconnected with conductive sil-
icone and a wire is introduced (Figure 3D ). It behaves as a high-
way to distribute the charges all along tube’s edges. In fix circled
numbers 9○ and 10○, silicone is added around the electrical inter-
connection to make inner and outer insulations.
Finally, an electric shield is deposited by deep coating ( 11○ in
Figure 2). This electric shield, connected to the ground, is a con-
ductive layer enclosing the DEA. Since positive electrodes as well
as their contacts are completely embedded in the shield, the elec-
tric field is confined in the dielectric structure. Therefore, once
implanted, there is very low risk to have a field or current leakage
in physiologic tissues (conductive and with high dielectric con-
stant).
With the tube’s inner diameter of 30 mm (in the active area)
and a total length around 60 mm (Figure 3), which can be reduced
to 50 mm with a lower safety distance for insulation, the DEA
could replace part of the ascending aorta of human, which is 8
cm long and circa 30 mm wide in diameter at rest.[17]
Aorta presents a complex mechanical behavior which de-
pends on the age, the patient, and potential pathology.[18–22]
Advance composite material,[23–26] could reproduce the strain-
stiffening behavior of a natural aorta, that is, the typical J-shaped
at 20–30% of deformation (Figure S23, Supporting Informa-
tion). This J-shaped ensures the mechanical stability (aneurysms
and “blowout”) in any highly distensible pressure vessel.[27–29]
Without this J-shaped, analysis of the mechanical stability in
the pressure–volume characteristic, as proposed in Figure 4, is
mandatory. In this work, the number of layers, that is, the total
thickness, has been chosen to mimic the average mechanical be-
havior of a real ascending aorta in a physiological range of pres-
sures (Figure S24, Supporting Information).
The electrical impedance, measured in the initial state at a
low voltage, is equivalent to a resistance of 10kΩ in series with
a capacitor of 1.6 nF giving a time response of dozens of mi-
croseconds, which is fast enough compared to the dynamics of
the heart.
2.2. Characterization of the Dielectric-Elastomer-Augmented
Aorta
A custom-made test bench has been built (Figure 4A and
Movie S1, Supporting Information), to measure the pressure–
displacement characteristic of the DEAA (tubular DEA) (Fig-
ure 4D). For this purpose, the DEAA has been placed in between
two coaxial tubes (Figure 4B) and a pneumatic set-up imposes
the pressure of the tube while an amplifier controls the voltage.
A laser line profile sensor measures the radial displacement of
the tube. The pressure–displacement characteristic shows up to
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Figure 4. Set-up and quasi-static measurements of the dielectric-elastomer-augmented aorta (DEAA)–tubular DEA with four layers of 200 µm. A) DEAA
under tests: The pressure, the volume, the voltage, and the current of the tube are measured. B) Sectional view of the mechanical set-up to maintain
the tube between two coaxial tubes. Through the radial holes, the tube is inflated with air. C) Deformation of the tube pressurized around 100 mmHg
when the voltage is on (12 kV) and off (0 kV), (measurements are in Figure S15, Supporting Information). D) Pressure–displacement characteristic of
the DEAA at different voltages according to measurements (full line) and computational finite-elements simulation (dash line). The measurements are
done in quasi-static conditions. Radial displacement is measured by a laser line profile sensor. Brown and black points correspond to the two states of
the DEEA of Figure 4C.
14 mm of displacement at 12 kV. Quasi-static measurement over
a full span of pressure and high voltages enlarge the hystere-
sis. Indeed, at a fixed voltage, the Maxwell pressure increases
when the film is squeezed what causes an amplification of the
hysteresis.
At 12 kV (brown line in Figure 4D), after reaching 105 mmHg,
there was a plateau: the volume of the tube increases while the
pressure remains constant. Our simulation even indicated the
pressure would even decrease for an increase of volume. This
behavior is not observable with a test bench imposing pressure as
it leads to a plateau (snap-through). Few characterizations where
the constant product (pressure × volume , Boyle’s law) is small
confirm this decrease in the curve pressure-volume (Figure S14,
Supporting Information).
Static 2D axisymmetric finite element simulations shows a
good agreement with measurements (Figure 4D). A perfect es-
timation of the behavior is difficult, this is because the elastomer
exhibits a hyperelastic behavior and a strong dependence to its
history[30] (Mullins effect Figure S22, Supporting Information).
Simulation in Figure 4D is used to illustrate the behavior of the
DEAA in the unstable region where the volume/displacement
increases while the pressure decreases (slope inversion). A
reduced strain-stiffening (J-shaped) elastomer response ac-
centuated by an applied electrical field has promoted this
instability.
In general, working with the highest voltage increases the
displacement and so the energy that will be transferred to the
fluid (Figure 4D). However, working at too high voltage increases
the risk of breakdown. In addition, imposing the pressure while
working above a certain voltage leads to instabilities,[31] thus in-
creasing the risk of premature failure. According to our experi-
ments, working in a reduced pressure range (up to 105 mmHg)
at 12 kV appears to be a safe operating voltage, while still reaching
high displacement, and thus high energy, thanks to the vicinity
of the plateau (Figure 4D).
3. Results
3.1. Interaction between the Dielectric-Elastomer-Augmented
Aorta and a Fluid
The mechanical work provided by the DEAA is the work of the
pressure forces all along the interface between the fluid and
the membrane of the DEA. For a homogeneous pressure in the
lumen of DEAA, the work becomes related to the area of the
pressure–volume cycle in the Figure 5. From the displacement
measured along the tube with the laser line profile sensor and
considering axisymmetric deformation, the volume of the DEAA
is estimated. In working conditions, the interaction between the
DEA and the pulsating human flow will define operating points
(pressure–volume) that will describe the cycle. Quasistatic mea-
surements gives a preliminary estimation of the energy that a
DEAA will provide when interacting with human cardiovascu-
lar system.
At constant voltage (0 or 12 kV), the operating point moves
along the quasi static characteristic of the DEAA according to the
voltage applied. A slow voltage switching, regarding the dynamic
of the flow, keeps a pressure balance along the aorta. Meanwhile
the change of aorta pressure being still slower than this switch-
ing, the pressure remains constant during the switching (con-
stant pressure trajectory, red dot line in Figure 4). As soon as the
dynamic of the voltage switching is faster than the dynamic of
the flow, the flow is not fast enough to compensate the drastic
change of local pressure in the lumen of the DEAA; therefore,
the volume does not change. After the transient time, the DEAA
follows the pressure imposed by the cardiovascular system (full
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Figure 5. Quasi static pressure–volume characteristic of the DEAA at 0
at 12 kV. The bold lines highlight the trajectories at constant voltage: in
red when there is a pressure balance between the DEA and the rest of
the aorta and in blue when there is a pressure unbalance. The red dash
lines show the transition considering a slow electrical switching, that is,
pressure balance. The blue dash dot lines give the path followed in case
of a fast voltage switching. The working human aortic pressure change
targeted with the proposed actuator is indicated since it is slightly different
from an healthy patient. The energy associated to the different area are also
indicated.
red lines in Figure 5) since the volume of the DEAA is four times
smaller than the one of the heart. In that case, the DEAA follows
a constant volume (CV) trajectory (blue dash-dot line in Figure 5).
These constant pressure (CP) and constant volume (CV) trajec-
tories circumscribe possible trajectories. They respectively shape
the CV–CP (constant voltage–constant pressure) and the CV–CV
(constant voltage–constant volume) cycles.
The hysteresis, which depends on the frequency, will affect
the cycle even though not working on the full range of pressure
would reduce its influence. Test bench experiments on the assist
CV–CP cycle confirms a cycle close to the two closest branches of
the hysteresis loop as drawn by the red curve in Figure 5 (Figure
S13, Supporting Information). The CV–CP cycle provides me-
chanical work of 50 mJ per cycle, roughly 6% of the energy pro-
vided by the heart and the CV–CV cycle goes up to 160 mJ, that
is, 18% of the energy provided by the heart.
3.2. Dielectric-Elastomer-Augmented Aorta in Pulsatile
Flow-Loop Replicating Physiological Aortic Pressure and Flow
Once implanted in the ascending aorta, the DEAA will interact
with a complex fluid dynamic system including valves, the left
ventricle, and the rest of the aorta. To test our device close to real
working conditions and estimate the energy that effectively as-
sists the heart, we built a pulsatile flow-loop replicating physio-
logical flow and pressure conditions[32,33] (Movie S3, Supporting
Information). This mock-up, so called “flow loop” (Figure 6A) is
designed to mimic the pressure and flow inside the ascending
aorta (i.e., where tubular DEA is placed). There are three main
parts (Figure 6C): i) the left part of the heart (left atrium and
ventricle), ii) the ascending aorta, and iii) the remaining circu-
latory system. A piston, moving back and forth cyclically (Figure
S20, Supporting Information), reproduces the contraction of the
left ventricle. The valves are mechanical valves clinically used for
valve replacement in patients. The DEAA replaces the ascending
aorta, just after the aortic valve. The remaining circulatory system
is made of a compliance chamber used to mimic the compliance
of the arteries and a flow resistance used to mimic the total pe-
ripheral resistances (i.e., the resistance of the microvascular net-
work). Pressures are measured in the compliance chamber (Pcc),
in the lumen of DEA (PDEA), and in the left ventricle (Plv). The
operating points between 65 and 105 mmHg (Figure 6B) were
tuned to be in the range of physiological pressure while avoiding
the aforementioned unstable area of DEA.
DEAA voltage follows the profile of the Figure 7 with a rising
time and falling time of 50 ms (around ten times faster than the
dynamic of the left ventricle). The voltage was activated when the
left ventricle (piston) starts to contract and deactivated 10 ms af-
ter it starts to expand (Figure S20, Supporting Information). The
application of the voltage increases the aortic deformation as ex-
pected (Movie S4, Supporting Information). Electrical based esti-
mation (350 mJ charge - 126 mJ discharge = 224 mJ transferred)
is not accurate because the DEA has losses both from the me-
chanical part and from the electrical part.[16] A direct approach
consists of estimating the mechanical work done by the DEAA.
For this purpose, a pressure probe (0.36 mm diameter) measures
the static pressure inside the DEAA (on the axis) thanks to a lat-
eral opening on the side of the tip (Figure 7A). Considering the
volume (estimated from laser line profile sensor Figure 6A) and
the pressure of the DEAA, its mechanical cycle as well as its work
are estimated (Figure 7B). The oscillations of PDEAA (Figure 7A)
result in a complex cycle with several loops (Figure 7B): counter-
clockwise loops provide positive energy (from the DEAA to the
flow) while clockwise loops give negative energy; the computed
energy is 80 mJ with assistance and 20 mJ without.
As expected, the pressure in the DEAA is lower with voltage
compared to the case without (Figure 7A). While the main shape
of the cycles in Figure 7B is in accordance with CV–CP cycle of
the Figure 5, minor loops are questionable. Without assistance,
the DEAA could not provide 20 mJ to the fluid, as it can only dis-
sipate energy (clockwise loops expected). In case of assistance,
it is not realistic that the minor loops, induced by the switching
from 12 to 0 kV, provides energy to the fluid (counter clockwise
loops). Minor dissipating loops (clockwise loops) should be ex-
pected. This high frequency component of the cycle comes from
disturbance in the static pressure measurement in the DEAA.
When the valve is closed and the DEAA contracts, a radial compo-
nent of the velocity is created which adds a difference of pressure
between the center of the tube and the pressure on the DEA’s
wall (inhomogeneous pressure on the lumen of the DEA). Last
but not least, the probe being designed to measure static pres-
sure (on the side of the tip) may be subjected to the effects of
this radial velocity (dynamic pressure). Finally, the complex flow
induced by these high-frequency oscillations (high speed and ra-
dial flow) prevents us to estimate accurately the pressure on the
surface of DEAA (as pointed out by the aforementioned inconsis-
tencies). Thus a direct and accurate quantification of the energy
transferred by the DEAA to the fluid is not trivial, especially for
the high frequency.
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Figure 6. Pulsatile flow-loop replicating physiological flow and pressure conditions. A) Top view of the flow loop focusing on the DEAA in between the
left ventricle and the compliance chamber. B) Temporal signal of the pressures in the compliance chamber (Pcc) and the left ventricle (Plv). Systolic and
diastolic phases are annotated. Schematic side view of flow loop’s behavior (piston, valves) and DEAA deformation during systole (C) and diastole (D)
with the state of the valves.
Figure 7. Effect of the DEAA in a pulsatile flow-loop replicating physiological flow. A) Pressure in the DEAA and in the compliance chamber with (assisted,
continous lines) or without (not assisted, dash-dotted lines) voltage. B) Pressure-volume of the DEAA in the flow loop with the energy provided and the
quasi static measurement of the DEAA at 0 and 12 kV (blue dash line).
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However, it is possible to analyze the energy exchange. This
energy transferred from the DEAA to the fluid in its lumen (and
surrounding regions) is carried out either through a work of pres-
sure (potential energy) at the outlet/inlet or through the kinetic
energy of the fluid going out or in the DEA. Equation based on the
energy flux[34] (modified Bernoulli’s equation) applied in the vol-
ume encircled by the DEAA describes the two energy exchanged
at the inlet and at the outlet:
dEfluid
dt













with Efluid the kinetic energy of the fluid inside the tube, WDEA
the mechanical work of the DEAA, P the average pressure in
the tube cross-section, v the average speed in the cross-section,
S is the cross-sectional area respectively for the inlet and the out-
let of the tube (with the respective subscript in and out), and
𝜌 the density of the fluid. For an integration over one cycle of
Equation (1), the derivative of the kinetic energy Efluid will disap-
pear (no dissipation assumed). Finally, the term resulting from
the mechanical work provided by the DEAA (Figure 5) goes to
potential energy (right hand first term) and the kinetic energy
(right hand second term), both due the fluid conveyed at the
inlet and at the outlet of the DEAA. When the pressure is ho-
mogeneous along the aorta (quasi-static transformation), such
as in the CV–CP cycle, the energy is only transferred as poten-
tial energy (i.e., 50 mJ of area circumscribed by the red line in
Figure 5). A difference of pressure due to the rapid expansion
or contraction of the tube (CV–CV cycle) will bring kinetic en-
ergy as well, since the fluid will be accelerated. In the case of
a fast switching, the kinetic energy released goes up to 100 mJ
when switching from 12 to 0 kV and up to 10 mJ when switch-
ing from 0 to 12 kV (i.e., areas circumscribed by the blue line in
Figure 5).
The kinetic energy released by the DEAA in the flow loop trig-
gered dampened pressure oscillation in the lumen of the DEAA
and in the compliant chamber (Figure 7A). Oscillations are al-
ways related to an exchange of energy between kinetic and po-
tential (elastic) energy. Most of the kinetic energy (100 mJ over
110 mJ in the case of a fast switching) is released when switch-
ing from 12 to 0 kV. In that case, the valve is closed and the kinetic
energy of the fluid is exchanged with the elastic energy due to the
deformation of the DEAA on one side and the compression of the
air inside the compliant chamber on the other side (Figure S17A,
Supporting Information). It is like an oscillating flow in a U-tube
where the gravity has been replaced on one side by the compres-
sion of air in the compliance chamber and by the DEAA on the
other side. As soon as the kinetic energy released by the DEAA is
completely transferred in the deformation of both the DEAA and
of the compliance chamber (i.e., the speed is null), the ampli-
tude of the deformation (related their pressure and volume) can
be used to estimate the kinetic energy released by the DEAA (Fig-
ure S17, Supporting Information). The estimated 200 mJ, while
the quasi static analysis shows a maximum of 100 mJ (Figure 5),
shows that this method grasps the oscillating mechanism, but it
is not enough to accurately estimate the kinetic energy released
by the DEA.
3.3. Dielectric-Elastomer-Augmented Aorta as a Cardiac Assist
Device
In regard to the heart, the pressures in the left ventricle and in
the compliance chamber (the “after-load” to be overcome by the
ventricle) are reduced when DEAA is switched-on just before the
opening of the aortic valve (Figure S20, Supporting Information),
compared to the condition without assistance. On the contrary,
the pressure in the compliance increases when DEAA is switched
off during diastole. To this end, the activation of DEAA expands
the aortic model just before the start of the systole, resulting in
a reduction of the minimum of Pcc (or end-diastolic pressure,
point I in Figure 8) from 65 to 60 mmHg and a lower maximum
pressure during systole (or peak systolic left ventricular pressure,
point II in Figure 8) from 107 to 100 mmHg. After the closure of
the aortic valve, the DEAA returns to its original diameter, which
leads to a diastolic augmentation of 3 mmHg (point III in Fig-
ure 8). The flow shows a similar pattern (Figure S16, Supporting
Information), characterized by a flow reduction during systole
which is compensated by the flow-increase during the diastole.
With or without assistance, the average flow rate in a cycle stays
constant (80.6 mL s−1 vs 80.4 mL s−1 with assistance or without,
respectively). The assistance was provided for every heart beat for
ten cycles. Figures 8 and 7 considers the periodic state. Results
(mean ± standard deviations) are shown in Table S1, Supporting
Information, and compared between the two groups (assisted ver-
sus not assisted cycles).
The pressure drop seen by the left ventricle when ejecting the
flow (afterload) is related to the energy saved. According to the
pressure and the volume of the left ventricle on the Figure 8, the
work done by the left ventricle is reduced (from 849 to 802 mJ) of
47 mJ thanks to the DEAA, that is, 5.5% of assistance.
The stroke volume of the piston was always kept constant dur-
ing the experiments.The results showed that the DEAA plugged
right after the aortic valve in the flow loop ensures a constant av-
erage flow (cardiac output), but at lower working pressures for
the heart, that is, lower energy is required to the heart to pump
the same amount of volume.
3.4. Comparison with Existing Aortic Counter-Pulsation Devices
The choice of placing “aortic counter-pulsation devices,” in
the ascending aorta, as we did in our in vitro experiment,
has been reported[35,36] as an option which maximizes cardiac
counter-pulsation effects. Counter-pulsation in ascending aorta
is considered more efficient because: 1) the closer the device
is to the aortic valve, the more synchronized the device can
be to the cardiac cycle; 2) pulse diffusion is minimized[35]
(because of the lower pulse spreading in other arteries); 3)
blood volume displacement in ascending aorta is enhanced,
resulting in more pronounced reduction of the end diastolic
pressure
The measurement of the energy of the left ventricle with
or without assistance allows a direct analogy with other
counter-pulsation devices. An absolute comparison is diffi-
cult due to different working conditions. However, a compar-
ison based on the percentage of assistance shows that we
have the same order of magnitude: In humans, Schreuder[37]
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Figure 8. Left ventricle relief thanks to the dielectric elastomer actuator. A) Pressure in the compliance chamber (aorta): The activation of DEAA expands
the aortic model just before the start of the systole, resulting in a reduction of the minimum of Pcc (or end-diastolic pressure, point I) from 65 to 60
mmHg and a lower maximum pressure during systole (or peak systolic left ventricular pressure, point II) from 107 to 100 mmHg. After the closure of
the aortic valve, the DEAA (switched-off) returns to its original diameter, which leads to a diastolic augmentation (point III). B) Pressure–volume cycle
of the left ventricle chamber (average of ten cycles). Energy values are provided for assisted and non-assisted condition
reported a decrease in the left ventricle work (from 4387
mmHg*mL = 583 mJ to 4170 mmHg*mL = 554 mJ) of 29
mJ, that is, 5% of assistance. In calves, Kawaguchi[38] reported a
decrease (from 914 mmHg*mL = 121 mJ to 849 mmHg*ml =
113 mJ) of 8 mJ, that is, 6.6% of assistance. Our DEAA assist de-
vice demonstrates a 47 mJ of assistance (from 848 to 802 mJ, Fig-
ure 8B), that is, 5.5% of the energy provided by the human heart
(Figure 8).
In the field of cardiovascular medicine, the pressure decrease
during the systole induced by any assisting device implanted in
humans is seen as a relief of the left ventricle. Even though pres-
sures provide a partial information of assistance, measurements
are easier. Kolyva[39] reported a diastolic aortic pressure augmen-
tation up to 21.1 mmHg and a reduction of the end-diastolic pres-
sure from 50.9 mmHg to 43.9 mmHg. In comparison to those
values, related to point III and point II of our results in Figure 8,
the diastolic aortic pressure augmentation with our DEAA goes
up to 3 mmHg while the reduction of the end-diastolic pressure
goes from 65 mmHg to 60 mmHg.
While the working principle is similar, the balloon of the IABP
is four to five times longer and it is placed into the descending
aorta. IABP with a size of 25 cm length and 16 mm of diameter
when inflated, works with a volume change of 40 cm3, four times
bigger than our device while its size is 5 cm long with only 3.5
cm active and 30 mm of diameter. An increase in the length of
the tubular-DEA could be a simple method to increase the energy
provided and/or the pressure drop (or increase). The heart assis-
tance not only being based on the pressure change or on the en-
ergy of the left ventricle saved, different strategies of assistance
depending on the pathology need to be delved into. Finally, in
vivo studies with the extra aortic balloon pump (EABP) and intra
aortic balloon pump (IABP) show benefits related to the effect,
the position of the device (ascending versus descending)[40], the
time of activation[37] (before or after the closing the valve), and
the effect in the coronary.[41]
4. Conclusion
A multilayer dielectric elastomer augmented aorta, for cardiac as-
sist, has been manufactured. Experiment in the flow loop shows
that only the potential energy of the DEAA (around 50 mJ) helps
the left ventricle. This energy can be transferred thanks to the
variation of pressure induced by the heart. Moreover in this proof-
of-concept study, we demonstrated that a dielectric elastomer ac-
tuator is elegant in its cooperation with the heart. On one hand,
the risk to rupture blood cells (create haemolysis) and of shear-
induced thrombocyte activation (blood clotting), major problems
encountered with other cardiac devices, are removed by augment-
ing the natural role of the aorta deformation in order to bring
energy to the flow. On the other hand, the dielectric elastomer
actuator has the benefit of the heart pressure to work efficiently.
By direct harness of the controlled stiffness of the DEA, no more
elements than the active material are required to make this device
light and well integrated.
4.1. DEAA Implantation
From the medical point of view, the system presented here shows
appealing features. In the event of power failure, our (unacti-
vated) DEAA shows a mechanical response in the same order
of magnitude than the natural aorta, providing a viable operat-
ing condition for the heart. In the case, the heart has recovered,
no further operation will be needed. By avoiding direct contact
to the heart, ascending aorta replacement will ease the surgical
insertion of the device. The silicone and the carbon-based sili-
cone electrodes are bio-compatible. The mechanical connections
between the tubular DEA and the aorta can follow the typical sur-
gical procedures (e.g. sewing and gluing) used for existing vas-
cular graft replacements of the ascending aorta[42] and for con-
necting the aorta to active devices such as total artificial hearts[43]
or para-aortic counter-pulsation devices[44]. However, further
Adv. Sci. 2021, 2001974 © 2021 The Authors. Advanced Science published by Wiley-VCH GmbH2001974 (9 of 13)
www.advancedsciencenews.com www.advancedscience.com
developments will focus on optimisation of the junction between
the aorta and the device. Last but not least, the DEAA, in future
developments, could be triggered either using ECG signals or us-
ing the DEAA itself (as both an actuator and a sensor, i.e., self-
sensing)[45].
4.2. Electrical Energy Transfer
The use of 200 µm thick films eases the fabrication process but
requires dedicated electronics with reinforced insulation and a
careful electric design. The electrical field, being fully confined
in the device, does not represent a risk for tissue damage (despite
the 12 kV applied). Due to this, there is a trade off between han-
dling electric insulation and tubular-DEA fabrication with thin-
ner films. DEA tube based on 100 µm thick film have also been
manufactured allowing a working voltage at 6 kV, but the pro-
cess is longer and not as reliable as with the 200 µm thick film.
The use of thinner film requires improvements in the fabrica-
tion process. A similar existing process,[46] with a film of 18 µm
and an electrode thickness of a few hundred nanometers, would
reduce, in our case, the voltage down to 1.2 kV, which can be eas-
ily manageable. Electrospray deposition[47] or organic molecular
beam deposition[48] can even go below micrometer thick films,
but then compliant metal electrodes have to be used in order to
support the increase of current[49,50]. The innovative properties
of DEAA technology includes lightweight and the lack of bulky
pneumatic drive lines, normally used to actuate the IABP’s bal-
loons. Both advantages simplify the possibility of developing fully
implanted DEAA device (using trans-cutaneous wireless power
transfer[51,52]) with the consequent reduction of infections (typi-
cal of transcutaneous drivelines). The net electrical energy pro-
vided is 224 mJ per cycle (1 s). It corresponds to 224 mW of aver-
age power (along the cycle). Considering a 90% efficiency of the
power electronic (250 mW) with Li-ion battery of a cell phone (10
Wh), we can expect an autonomy of 40 h.
4.3. DEA Limitations
Apart from material improvement related to its chemistry com-
position and to the process used to produce the film, the tubular-
DEA has to be designed to have the maximum operating area in
the pressure range of the aorta while keeping a safe condition of
operation. A fine optimization is difficult for two reasons. First,
the breakdown limit is hard to predict as it strongly depends on
the deformation[53] and on the type of deformation (biaxial or uni-
axial). Second, since the DEAA is designed to work close to the
plateau (to increase the amount of delivered energy), variability
in the fabrication or due to its deformation history is critical. For
example, a similar tube we made has reached a mechanical insta-
bility at 80 mmHg (12 kV) (Figure S14, Supporting Information)
instead of of 105 mmHg (Figure 4). In our approach, we adapted
the working pressure range (65–105 mmHg instead of the stan-
dard physiological range 80–120 mmHg) to avoid the unstable
region. This reduction could be associated to an ill heart but here
it is needed to safely operate the designed DEA.
4.4. Mode of Actuation
Only the energy related to the CV–CP cycle seems interesting for
the left ventricle in our flow loop. Although the mode of actua-
tion suggests the possibility to push the level of assistance up to
160 mJ, our choice of having rising/falling time for DEAA activa-
tion/deactivation of 50 ms ensures small and safe oscillation in
the flow loop. Faster switching time that releases more kinetic en-
ergy is not relevant. Indeed, the two element lump system, that is,
the compliant chamber and the total peripheral resistance (TPR),
is not reliable to describe the high-frequency behavior (oscilla-
tion) of a real body (continuous media with waves propagation
and reflection). In humans, different actuation modes as well as
harnessing interaction between the DEAA and complex human
circulatory system could be explored to better exploit the total en-
ergy that the DEAA could transfer.
5. Experimental Section
Fabrication of a Module: A module (Figure 3B) was obtained by depo-
sition of an electrode on top of a silicone film (Elastosil film 2030, Wacker,
Munich, Germany) with its PET support as provided by the manufacturer.
The carbon ink for the electrode[54] was deposited on the Elastosil with
its support by an automatic film applicator coater and a universal appli-
cator (Zehntner ZAA 2300 and ZUA 2000, Proceq Group, Switzerland) at
20 mm s−1 through a mask made with a 13 µm thick PET film (ES301130,
Goodfellow) and a 50 µm thick scotch tape (Magic scotch, 3M, SA). Two
successive ink depositions are made, giving an ≈10 µm thick electrode af-
ter curing for 1 night at 80 °C. Finally, the sheet resistance measured with a
two points method is of 4, 8, and 12˜kΩ.square, respectively, for a uni-axial
strain of 0%, 50%, and 100%.
Fabrication of the Multi-Layer DEA: The manufacturing of the multi-
layer structure consisted of stacking two modules on top of each other.
First, a silicone adhesion layer,[16] was deposited with the film applicator
coater on a PET substrate (Mylar Typ. A, 125 µm, DuPont Teijin Films,
USA) at 20 mm s−1 with a profile rod 4.57 um (Zehntner ZSA 2110 Wire-
bar applicator, Proceq Group, Switzerland). The module was reported on
the adhesion layer with the profile rod to mimic a laminator. The stack
was then put in the oven for 2 h at 80 °C. Finally, the PET supporting the
Elastosil film was peeled off. These steps were then repeated to increase
the number of layers. On the last Elastosil layer, the last electrode was
deposited. At the end, electrodes were interdigited such as in multilayer
ceramic capacitor and the stack was removed from its PET support (Fig-
ure S9, Supporting Information). The active area was 19 cm long and 35
mm large. The intermediate adhesion layer, ≈5 µm thick did not show dif-
ference on the pull-tester. The number of reported modules was two for
200 µm thick films (or four for 100 µm thick films).
Fabrication of the Tube: Being larger than the final size, the stack was
cut close to its final size. Before rolling the tube, a silicone layer (Silbione
LSR4305, Elkem) was deposited on the bottom of the stack (Figure 2 ⑤;
Figure S9, Supporting Information) with the profile rod in order to glue the
layers during the rolling. The film, adhering to a poly-methyl-methacrylate
(PMMA) tube (30 mm diameter) was simply rolled by hand (Figure S10,
Supporting Information). The tube was cut across the whole thickness on
both edges to reach the different electrodes. The carbon based silicone
(Elastosil LR3162 12 gr mixed with 6 mL of Belsil DM 1 Plus, Wacker, Ger-
many) was applied with a syringe at edges of the tube for the electrical
connections. A zig-zag copper wire was bent inside the LR3162 to follow
the curvature of the tube. The edges of the wire were abraded using sand
paper to improve the adhesion to the carbon-based silicone and remove
the insulating housing of the wire. The tube was then placed in the oven
24 h at 80 °C.
Insulation and Shielding: A custom-made rotating machine was used
to perform the outer insulation. When the tube was rotating, silicone (Syl-
gard 186, Dow) was added with a syringe. Curing was done first at ambient
temperature and second in an oven for 2 h at 80 °C. For the inner insula-
tion, the DEA tube was removed from its PMMA support-tube using iso-
propanol as lubricant. A mold, made of a short PMMA cylinder (30 mm
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outer diameter, 26 mm inner diameter) and a PET film rolled inside the
PMMA cylinder was done (Figure 2 10○). The silicone was then injected in
between the PET and the PMMA tube and cured for 2 h at 80 °C. The inner
and the outer insulation of the high way were at least 2 mm thick (Figure
S11, Supporting Information). Finally, carbon ink (same as the one used
for the electrodes) was deposited by deep coating on the positive edge
to realize the electric shielding, and a coaxial cable (KSIK18HV2619 SPC,
Axon, France) was used to connect the positive electrode. The tube was
checked using an optical microscope in Figure 3E (Figure S12, Support-
ing Information, for the 200𝜇m thick film).
Electrical Measurement: The electrical impedance of the final tubular
DEA, measured using an impedance meter (precision impedance Analyzer
4294A, Agilent, USA)was fitted with a capacitance in series with a resis-
tance. For the 100 µm thick film, the capacitance was 6.4 nF and the re-
sistance was 4 kΩ, while for 200 µm thick film, the capacitance was 1.6 nF
and the resistance 10kΩ. Because the tube based on 200 µm thick film was
faster to produce and easier to handle, this study was focused on 200 µm
thick film based tube, even though realizations based on 100 µm thick film
have also been achieved. Regarding the sheet resistance, the value could
be improved but a time response of dozens of microseconds was already
enough for this application.
Quasi-Static Test Bench: Once produced, the tubular multi layer DEA
was then placed in between two coaxial PolyOxyMethylene (POM) tubes
(outer diameter 30 mm); Figure 4 shows how DEA’s edges are fixed to
the POM tubes with elastic tape (polyvinyl tape) all around. On the bot-
tom side of the tube holder, a pressure sensor (PBMN-258 1 2R A21
44621 2000, Baumer, Germany) was connected while on the top side, the
tube was connected to the pneumatic set-up composed of a dead volume
(SMC 1L CP96 I63, Bosch) and a moving piston (SMC CP96 SDL40-300C,
Bosch) driven with a motor and a screw nut system (Rexroth FMS-080-
SN-1, Bosch). The dead volume (1 L) gave the capability to stay close to
a constant pressure even when the DEAA was on (Figure S15, Support-
ing Information). The dead volume could also be disconnected to have
constant product (pressure × volume = constant, Boyle’s law). The pres-
sure was measured via a pressure sensor (PBMN-258 1 2R A21 44621
2000, Baumer) and using a data acquisition card (NI-6259, National In-
struments, USA). A laser line profile sensor (Gocator 2430A-2-R-01-S, LMI
Technologies) measuring the radial displacement of DEAA was synchro-
nized with the pulses generated by the acquisition card at 100 Hz. By in-
tegrating the data of the line profile sensor along the tube and assum-
ing an axisymmetric system, the volume of the tube was estimated. The
electrical terminals of the DEAA were connected to a 20 kV voltage ampli-
fier (20/20C-HS, Trek, USA) through a 20 MΩ resistance in order to limit
the current in case of breakdown. Finally, the current and the voltage of
the DEAA are measured using custom-made voltage divider and a tran-
simpedance converter with a 10 kΩ resistance.
The tube was characterized at low frequency (quasi static), following
pressure profile as a triangle wave with maximum pressure reached in 20
s. Before starting the measurement, the tube was mechanically cycled with
a pressure significantly above the working pressure as tentative to uniform
the tube’s history (Mulling effect, Figure S22, Supporting Information). In
this work, we did three cycles up to 200 mmHg.
The quasi static test bench was also used to characterize the tube in
other operating conditions. For instance, the tube was put under constant
pressure while the voltage was switched-on and -off (Movie S2 and Figure
S15, Supporting Information).
Quasi-Static Test Bench: Modeling: 2D axisymmetric finite elements
analysis (COMSOL Multiphysics software, USA) was done using a fully
coupled model. Assuming symmetry between the upper part and the bot-
tom part, only half of the tube was simulated. The hyperelastic material
model was based on Yeoh’s model. To evaluate the parameter of such
model, an elastosil silicone membrane was characterized in pure shear
configuration (10 cm × 1 cm) on a pull tester at 2 mm s−1 (Instron se-
ries 3340 with the load cell of 50 N) (Figure S21, Supporting Information).
The pure shear deformation was preferred because it was close to the one
withstood by the tube. To estimate the parameters of the hyperelastic ma-
terial model (Yeoh’s model with c10 = 0.2 MPa, c20 = 0, c30 = 500 Pa), the
measured curve was fitted by introducing the pure shear deformation in
the model. Assuming an incompressible material, the bulk modulus was
taken high (200 MPa). Membranes and stacked membranes behaved ac-
cordingly in the pull-tester. According to manufacturer (Wacker, Germany)
specifications and to the study measurements, a relative permittivity of
2.8 was used in the model. In the simulation, either the pressure or the
displacement was imposed in the tube, depending on how close to the
instability area.
The simulation of a tubular DEA combines a dual challenge: the
electro-mechanical instabilities and the ones due to the inflation of soft
cylinder.[31] Those modes were avoided either in simulations or in experi-
ments.
Flow Loop: The flow loop (Figure 6A and Figure S18, Supporting In-
formation) was characterized by: an atrium, a left ventricle, a DEA tube,
a compliance chamber, and a TPR. A technical drawing is shown in Fig-
ure S19, Supporting Information. The valves were mechanical valves clini-
cally used for valve replacement in patients with a nominal diameter of 29
mm (29AGFN-756, Abbott, IL, USA) and 27 mm (27AGFN-756, Abbott,
IL, USA) were used for mitral (between left atrium and left ventricle cham-
ber, Fig. 7) and aortic valve (between left ventricle chamber and ascending
aorta), respectively.
The left ventricle, made of PMMA, was a cubic chamber with side length
of 110 mm. The left ventricle chamber was separated by the actuation part
by a “silicone membrane” whose expansion/compression was controlled
by the piston pump. The volume change of the left ventricle was controlled
by the displacement (Figure S20, Supporting Information) of the piston.
The controller (model Xemo R294 U, Demcon, Germany) drives the mo-
tor (Ecostep-Motor 34S42, Demcon, Germany) to achieve physiological
values at 60 beats min−1. The whole setup was filled with deionized water.
The compliance chamber had enclosed a certain air volume which could
mimic the arterial compliance, due to air compressibility. Compliance was
adjusted by regulating the water level in the chamber. The compliance
chamber made of PMMA was 120 mm in length, 110 mm in width, and
290 mm in height. The water level at rest was 181 mm, while the maxi-
mum level (with the system running) was around 199 mm. DEA tube was
mounted between the left ventricle chamber and the compliance chamber.
The tunable resistance was a custom-made resistor mimicking the pe-
ripheral resistances of the systemic circulation. It consisted of a cylindrical
element which had an outlet slot with controllable aperture.[33] The flow
resistance was measured around 184 Pa.s m−3 and the resistance con-
nected the compliance chamber and the atrium chamber with a tygon tube
(to close the loop).
Flow Loop: Tuning and Measurement in the Flow Loop: Several up-
grades were made to the flow loop.[32,33] The line profile sensor to measure
the radial displacement of DEAA and a pressure-wire probe (ComboWire
XT9515, volcano console, Philips, The Netherlands) 0.36 mm wide were
added to characterize the DEA. The static pressure inside the DEA’s lu-
men was measured 1.5 cm from the tip of one side of the wire. The probe
measured the pressure on the axis of the DEA. The probe was suspended
through a thin PMMA frame (Figure S18, Supporting Information). The
probe delay was measured (approximately 8.5 ms). The pressure sensor
(PBMN-258 1 2R A21 44621 2000, Baumer, Germany) in the compliance
chamber and in the left ventricle were plugged on the walls of the tanks
(Figure 6). In order to measure the flow in the total peripheral resistance,
a flow probe (ME16PX, Transonic, USA) was plugged on the tygon tube
between the TPR and the left atrium.
The exact operating points of pressure and flow were found by finely
tuning the total peripheral resistance, the volume of air in the compliant
chamber, and the movement prescribed for the piston (Figure S20, Sup-
porting Information).
The acquisition card (NI-6259, National Instruments, USA) was initially
triggered by the piston displacement, which was driven by a dedicated con-
troller. The acquisition card generated the reference voltage for the voltage
amplifier while it measured pressure, voltage, current, and flow. DEAA volt-
age profile (Figure 7A) had a rising time and falling time of 50 ms, and it
was switched on 50 ms before the piston moved forth and switched off
50 ms after it moved back. From the current and the voltage, the energy
needed to charge and discharge the DEA was deduced. All tested data were
carried out and plotted with Matlab (R2019b).
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Table 1. Flow loop experiment.
PCCmin [mmHg] PCCmax [mmHg] Qmax [mL.s−1] Qavg [mL.s−1] Stroke work [mJ]
Not-assisted group 65.1 ± 0.5 107.2 ± 0.6 94.2 ± 0.6 80.62 ± 0.3 849 ± 12.7
Assisted group 60.0 ± 0.7 99.8 ± 0.5 91.2 ± 0.5 80.41 ± 0.5 802 ± 16.3
p-Value 0.00004 (*) 0.00004 (*) 0.00004 (*) 0.422 0.00016 (*)
For each cardiac cycle, minimum (PCCmin) and maximum (PCCmax) value of PCC, maximum (Qmax) and average (Qavg) value of Q and the stroke work were determined.
Values for each group (not-assisted and assisted) are expressed as mean ±. For each group N = 10 cycles were considered. The Wilcoxon rank sum test (ranksum) was
performed to compare the two groups (not-assisted vs assisted). A p-value of less than 0.05 (indicated by “*”) was considered significant.
Statistical Analysis: The following signals from flow loop experiments
were sampled at 100 kHz for the compliance chamber (PCC), pressure in
the lumen of DEA (PDEA), and at 2 kHz for pressure in the left ventricle
(PLv), flow in the total peripheral resistance (Q), volume in the left ventri-
cle. The resulting time series were smoothed with a third-order Savitzky–
Golay filter Matlab (Mathworks, Natick, MA, USA) using windows of 99
points. For each cycle, the minimum (PCCmin) and maximum (PCCmax)
value of PCC, maximum (Qmax) and average (Qavg) value of Q, and the
stroke work (i.e., area of pressure - volume curve in the left ventricle 8) were
determined (Table 1). All these values were grouped in two groups: “As-
sisted group” and not “not assisted group.” The Wilcoxon rank sum test
(ranksum) was performed using Matlab (Mathworks, Natick, MA, USA)
to compare the values in the two groups. A p-value of less than 0.05 was
considered significant.
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